Skip to main content
American Journal of Respiratory Cell and Molecular Biology logoLink to American Journal of Respiratory Cell and Molecular Biology
. 2010 Jul 23;44(6):794–803. doi: 10.1165/rcmb.2010-0098OC

Functional Analysis of Two Distinct Bronchiolar Progenitors during Lung Injury and Repair

Roxana M Teisanu 1,*, Huaiyong Chen 1,*, Keitaro Matsumoto 1, Jonathan L McQualter 2,3, Erin Potts 2,3, W Michael Foster, Ivan Bertoncello 2,3, Barry R Stripp 1
PMCID: PMC3135841  PMID: 20656948

Abstract

Air spaces of the mammalian lung are lined by a specialized epithelium that is maintained by endogenous progenitor cells. Within bronchioles, the abundance and distribution of progenitor cells that contribute to epithelial homeostasis change as a function of maintenance versus repair. It is unclear whether functionally distinct progenitor pools or a single progenitor cell type maintain the epithelium and how the behavior is regulated in normal or disease states. To address these questions, we applied fractionation methods for the enrichment of distal airway progenitors. We show that bronchiolar progenitor cells can be subdivided into two functionally distinct populations that differ in their susceptibility to injury and contribution to repair. The proliferative capacity of these progenitors is confirmed in a novel in vitro assay. We show that both populations give rise to colonies with a similar dependence on stromal cell interactions and regulation by TGF-β. These findings provide additional insights into mechanisms of epithelial remodeling in the setting of chronic lung disease and offer hope that pharmacologic interventions may be developed to mitigate tissue remodeling.

Keywords: bronchiolar stem cell, Clara, progenitor, fractionation, epithelium


CLINICAL RELEVANCE.

This research provides additional insights into mechanisms of epithelial remodeling in the setting of chronic lung disease and offers hope that pharmacologic interventions may be developed to mitigate tissue remodeling.

The adult mammalian lung is a quiescent organ composed of many specialized cell types. These cells contribute directly or indirectly to the dual roles of the respiratory system: gas transfer between inspired air and the blood and protection against injurious toxins and microorganisms that gain entry to the body through the air or systemic circulation (1). Epithelial cells lining airways represent the primary barrier to inspired injurious agents. They include progenitor cells, which can proliferate in response to injury, leading to self-renewal or to the generation of other specialized epithelial cell types. The properties of epithelial progenitor cells change as a function of developmental stage and anatomic location within airways (2, 3). During lung development, multipotent progenitor cells located at the growing tips of airways proliferate during the embryonic period to generate progeny that become lineage restricted in the late fetal and adult airway (4, 5). The identity and function of progenitor cells that maintain bronchiolar airways in the adult has been the subject of numerous investigations yet remains somewhat controversial.

Experimental evidence supporting the existence of more than one type of functionally distinct bronchiolar progenitor cell that act in concert to maintain bronchiolar airways comes from studies using different chemical injury models to promote epithelial repair. Exposure of rats to inhaled nitrogen dioxide or ozone results in the proliferation of a nonciliated bronchiolar cell, initially referred to as a type A cell (6), that is generated from Clara cells through loss of secretory granules and smooth endoplasmic reticulum (7). Using pulse-chase DNA labeling methods, proliferating type A cells were shown to generate Clara cells and ciliated cells. Thus, Clara cells represent an abundant, broadly distributed pool of progenitor cells that contribute to repair after injury to postmitotic epithelial cell types of airways. The presence of another progenitor cell type that can renew depleted Clara cells is supported by in vivo studies involving Clara cell–selective injury models. We and others have used a naphthalene injury model to specifically ablate Clara cells (8). Naphthalene is bioactivated to a toxic derivative by cytochrome P450 isoforms expressed within Clara cells, leading to cell death (912). Proliferative naphthalene-resistant progenitor cells localize adjacent to neuroepithelial bodies (NEB) and at bronchoalveolar duct junctions (BADJ) and renew an epithelium containing ciliated and nonciliated cells (1315). Naphthalene-resistant bronchiolar progenitor cells express the marker Clara cell secretory protein (CCSP) and potentially prosurfactant protein-C (BADJ-associated naphthalene-resistant cells) and expand beyond NEB- and BADJ-microenvironments after endogenous potentiation of canonical Wnt signaling (13, 14, 16, 17). Furthermore, NEB- and BADJ-associated cells proliferating after naphthalene exposure generate progeny with a DNA label–retaining phenotype (13, 14). Together these data suggest that multiple bronchiolar progenitor cells exist within bronchioles that have the potential to play distinct roles in epithelial maintenance and repair.

Recent findings using lineage tracing and chimeric mouse models suggest that broadly distributed abundant progenitor cells rather than rare, specialized progenitor cells maintain the normal airway epithelium (18, 19). Rawlins and colleagues also demonstrate that lineage-tagged CCSP-expressing cells are capable of long-term self-renewal in bronchiolar airways (18). A key question is whether apparently different bronchiolar progenitor cell subsets that are activated in response to ozone or naphthalene-induced airway injury are functionally distinct populations or part of a common progenitor cell pool. Recent efforts have focused on the prospective isolation and development of in vitro and transplantation assays to assess the behavior of epithelial progenitor cells (17, 2024). Kim and colleagues prospectively isolated lung epithelial cells with the surface phenotype of CD45neg CD31neg Sca-1pos CD34pos that coexpressed CCSP and pro-SPC. These cells gave rise to clonal populations of cells that expressed alveolar or bronchiolar differentiation markers in vitro and were termed “bronchioalveolar stem cells” (17). However, recent lineage-tracing studies investigating the behavior of CCSP-expressing cells in vivo have failed to identify cells in terminal bronchioles that give rise to descendants in the alveoli during steady state or after alveolar damage (18). In our previous work, we found that Sca-1hi CD34pos cells do not belong to the bronchiolar lineage and that Sca-1, although expressed on the surface of bronchiolar epithelial cells, does not distinguish between naphthalene-sensitive or -resistant bronchiolar cells (22, 23). We showed that the CD45neg CD31neg CD34neg (Linneg) Sca-1low fraction contains two specific populations of cells with high or low autofluorescence (AFhi and AFlow). Moreover, we show herein and in our previous studies (22) that the AFlow population was dramatically increased in the airways of mice in which naphthalene-resistant bronchiolar progenitor cells were expanded through endogenous expression of an activated form of β-catenin. In this article, we further refine methods for the fractionation and enrichment of distinct epithelial progenitor cell subsets that survive and proliferate after various in vivo injury models. We show that the AFlow population accounts for the bulk of proliferative progenitor cells contributing to repair after naphthalene-induced airway injury, whereas the AFhi population represents a naphthalene-sensitive population that proliferates in response to ozone exposure. These data suggest that two progenitor pools exist within bronchioles that differ in their contribution to epithelial maintenance depending upon the type of airway injury. Furthermore, we show that these progenitor cell populations efficiently proliferate in an in vitro assay and that the abundance of colony-forming cells is proportional with the number of CCSP-expressing cells present in each fraction.

MATERIALS AND METHODS

Animal Husbandry

Experimental animals were maintained in pathogen-free conditions in animal facilities approved by the Association for Assessment and Accreditation of Laboratory Animal Care at Duke University. Animal housing and experimentation was performed according to protocols approved by the Institutional Animal Care and Use Committee on mice between 2 and 6 months of age.

Transgenic Mouse Strains and Genotyping

Genomic DNA was isolated from mouse tail according to previously published methods (22). PCR genotyping was performed using previously described conditions and primer pairs that are summarized for each line in Table 1 (16, 25, 26).

TABLE 1.

TRANSGENIC ANIMAL MODELS

Genotype Common Designation Source or References
CCSP-cre Thomas J. Mariani (University of Rochester, Rochester, NY) (16)
CatnbfloxE3 Makoto M. Taketo (Kyoto University Global COE Program, Japan) (47)
B6.129(Cg)-Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J ROSA-R/G Jackson Labs (Bar Harbor, ME)
Germline recombined B6.129(Cg)-Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J ROSA-EGFP
Scgb1a1-CreER; CCSP/Cre ER Brigid L.M. Hogan (Duke University, Durham, NC) (18)
FoxJ1-GFP FoxJ1 GFP Lawrence E. Ostrowski (University of North Carolina, Chapel Hill, NC) (25)
SP-C-GFP SP-C GFP Bernice Jo et al., 2008 (26)

Bromo-deoxyuridine Administration

5-Bromo-2′-deoxyuridine (BrdU) (Sigma, St. Louis, MO) was resuspended in pyrogen-free 0.9% NaCl solution (B. Brown Medical Inc., Irvine, CA) at a concentration of 6 mg/ml and administered intraperitoneally at 50 mg/kg body weight at the indicated intervals.

Ozone Injury

Age- and gender-matched C57Bl/6 mice (Jackson Laboratories, Bar Harbor, ME) were exposed to 1.5 ppm ozone or filtered air for 12 hours. Mice were removed from their housing cages and placed separately into individual stainless steel wire cage units. These units were placed into a 55-liter stainless steel Hinners-style exposure chamber. The chamber was equipped with a high-efficiency filtered air supply, such that chamber air (relative humidity, 50–60%; 20–22°C) was renewed at the rate of approximately 20 changes per hour. Ozone was generated by passing 100% oxygen gas through an ultraviolet light source. The ozone concentration was monitored continuously within the chamber with an ozone ultraviolet light photometer (model 1003AH; Dasibi Environmental Corp., Glendale, CA).

Naphthalene Injury

Naphthalene exposures were performed using 10-week-old male C57BL/6 mice. Naphthalene (Fisher Scientific, Fair Lawn, NJ) was dissolved in corn oil at a concentration of 25 mg/ml and administered by intraperitoneal injection at a dosage of 250 mg/kg body weight.

Flow Cytometry

Suspensions of lung cells were isolated by elastase digestion and stained for flow cytometry as previously described (22). The specificity and source of antibodies used are indicated in Table 2. 7-amino-actinomycin D (0.25 μg/100 μl staining buffer; BD Biosciences, San Diego, CA) was used for dead cell discrimination. Intracellular staining for BrdU was performed using the BrdU FITC kit from BD Biosciences according to the manufacturer's instructions. For intracellular staining for CCSP, AFhi and AFlow cells were sorted as detailed above and fixed with BD Cytofix/Cytoperm (BD Biosciences, San Diego, CA) according to the manufacturer's instructions. Cells were stained with rabbit anti-mouse CCSP antibody (1:100 dilution, in house), followed by Alexa Fluor 594 donkey anti-rabbit IgG (1:100 dilution) (Invitrogen, Carlsbad, CA).

TABLE 2.

ANTIBODIES USED FOR FLOW-CYTOMETRY AND TISSUE HISTOLOGY

Antigen Host Titer Source
CCSP Rabbit polyclonal 1:100 (FC) In house
CCSP Rabbit polyclonal 1:10,000 (IF) In house
proSP-C Rabbit polyclonal 1:3,000 (IF) Kind gift from P.Y. Di
BrdU Mouse 1:100 (FC) BD Biosciences (San Jose, CA)
GFP Chicken polyclonal 1:4,000 (IF) Abcam (Cambridge, MA)
Cytokeratin 18 Mouse monoclonal IgG1, clone # c-04 1:500 (IF) Abcam
Sca-1 Rat IgG2A, clone D7 1:200 (FC-Biolegend) Biolegend (San Diego, CA)
EpCAM (PE-Cy7) Rat IgG2A, clone G8.8 1:200 (FC), Biolegend
CD45 (biotinylated) Rat IgG2B, clone 30-F11 1:200 (FC-eBioscience) eBioscience (San Diego, CA)
CD31 (biotinylated) Rat IgG2A, clone 390 2.5:100 (FC) eBioscience
CD34 (biotinylated) Rat IgG2A, clone RAM34 6.5:100 (FC) eBioscience

Definition of abbreviations: BrdU = 5-bromo-2′-deoxyuridine; CCSP = Clara cell secretory protein; FC = flow cytometry; GFP = green fluorescent protein; IF = immunofluorescence.

RNA Isolation and Real-Time PCR

Total RNA was isolated from cells using a SV Total RNA (Promega, Madison, WI) isolation kit according to the manufacturer's instructions. Real-time RT-PCR was performed as described previously (27), and samples were read using an Eppendorf realplex Real Time PCR System (Eppendorf, Hauppauge, NY) (4).

Cell Culture

Sorted lung epithelial cells were resuspended in growth factor–reduced Matrigel (BD Biosciences), which was diluted at a ratio of 1:1 with basic culture medium. Basic medium contains DMEM/F12 (Cellgro; Mediatech Inc., Manassas, VA) supplemented with insulin/transferrin/selenium (Invitrogen), 10% FBS (Invitrogen), 0.25 μg/ml amphotericin B, 100 IU/ml penicillin, 100 μg/ml streptomycin, and 10 μM SB431542 (Ascent Scientific LLC, Princeton, NJ). Cells suspended in Matrigel were added to the chamber of 24-well Transwell filter inserts (Becton Dickinson, Franklin Lakes, NJ) and placed in 24-well, flat-bottom culture plates containing medium. Where specified, mouse lung fibroblasts (MLg, ATCC) were added to the Matrigel at 2 × 10 (6) cells/ml. Cultures were maintained at 37°C in a humidified incubator (5% CO2), and the medium was replaced every other day. Colonies were visualized with an inverted fluorescent microscope (Axiovert40; Carl Zeiss MicroImaging Inc., Thornwood, NY). Colonies were defined as clusters of green fluorescent protein–positive (GFPpos) cells greater than 100 μm in diameter. Serial passage of GFPpos cells was achieved by dissociation of Matrigel cultures with dispase (1 mg/ml) (Stemcell Technologies, Vancouver, British Columbia, Canada) for 1 hour at 37°C, sorting using a FACS Vantage (BD Biosciences), and reseeding cells into Matrigel cultures in the presence of MLg fibroblasts and SB431542 as described previously.

Histology and Immunostaining

Cultures of lung epithelial cells were fixed by the addition of 4% paraformaldehyde in PBS overnight at 4°C. Fixed colonies in their Matrigel supports were rinsed with PBS, immobilized in 1.5% agarose, embedded in paraffin, and sectioned at 5-μm thickness. Lung tissue was inflation fixed by instillation of 10% neutral buffered formalin and immersed in 10% neutral buffered formalin for 2 hours at 4°C. Right caudal lobes were embedded in paraffin and sectioned at 5-μm thickness. Sections were deparaffinized in xylenes, transferred to 100% ethanol, and rehydrated in decreasing concentrations of ethanol in PBS. Antigen retrieval was then performed by maintaining sections in 10 mM citrate buffer (pH 6.0) at approximately 95°C for 10 minutes using a microwave. Slides were blocked in 5% BSA (wt/vol) in PBS, followed by incubation with the primary antibody and with a fluorescent secondary antibody (Table 2). Expression of GFP was monitored by immunofluorescence analysis using a chicken anti-GFP antibody followed by Alexa Fluor 488–conjugated goat anti-chicken secondary antibody. Slides were then mounted in DAPI containing Fluoromount-G (2 μg/ml) (Electron Microscopy Sciences, Hatfield, PA). Fluorescent images were acquired using a Zeiss Axiovert 40 inverted microscope equipped with AxioCam MRc5 and MR digital cameras (Carl Zeiss MicroImaging Inc.). Images were processed and analyzed using Adobe Photoshop (Adobe Systems Inc., San Jose, CA).

RESULTS

Phenotypic Characteristics of Fractionated Lung Epithelial Cells

Previous studies by us and others have developed fractionation approaches, allowing enrichment of putative tissue stem cells (17, 20, 22). However, these approaches fail to completely account for the full spectrum of epithelial progenitor cells that may participate in normal tissue maintenance and repair. We have shown that airway epithelial cells are enriched in the CD45neg/CD31neg/CD34neg/Sca-1low (Linneg/Sca-1low) fraction of total adult mouse lung cells. This population could be further fractionated to enrich for subpopulations of epithelial cells: naphthalene-sensitive Clara cells (high autofluorescence) or naphthalene-resistant cells (low autofluorescence). We have adopted this fractionation strategy and coupled it with surface staining for EpCAM, considered to be an epithelial-specific cell adhesion molecule (28, 29), to further enrich epithelial cells and segregate according to Sca-1 surface expression (Figures 1A and 1B). Consistent with our previous data, the autofluorescence profile of the Sca-1low fraction revealed distinct AFhi and AFlow populations (Figure 1C). Furthermore, AFhi cells were depleted by activation of β-catenin signaling within airways (of Linneg cells, 18.4% for wild-type and 4.8% in CatnbΔE3 mice), resulting in the expansion of cell numbers within the AFlow fraction (11.4% for wild-type and 20.7% for CatnbΔE3 mice) (Figures 1A–1C).

Figure 1.

Figure 1.

Cell surface phenotype and autofluorescence characteristics of epithelial cells of the lung. (AC) Isolated lung cells were stained and analyzed by flow cytometry. (A) Exclusion of Linpos cells (x axis) and 7AADpos cells (y axis). (B) Sca-1 (x axis) versus EpCAM (y axis) analysis of 7AADneg/Linneg population from A. (C) Autofluorescence analysis of cells in EpCAMpos Sca-1low gate showing the high-autofluorescence (AFhi) and low-autofluorescence (AFlow) populations. The representation of AFhi and AFlow cells as a function of 7AADnegLinneg cells is indicated as a percentage. (DF) The abundance and distribution of Clara cell secretory protein (CCSP)-expressing cells within AFhi and AFlow fractions of the EpCAMpos/Sca-1low population was determined by intracellular staining coupled with flow analysis.

To define the contribution of CCSP-expressing cells to the AFhi and AFlow fractions, intracellular staining was performed to quantify CCSP immunoreactivity. Differences were observed between AFhi and AFlow fractions in the number of CCSP-positive cells and the level of CCSP expression (Figures 1D–1F). Analysis of cells within the AFhi fraction revealed that greater than 90% showed high levels of intracellular CCSP immunoreactivity (Figure 1E). In contrast, cells within the AFlow fraction included weakly CCSP-immunoreactive cells that represented approximately 11% of total cells within the AFlow population (Figure 1F).

Cell phenotypes within each fraction were assessed using reporter transgenic mice. We used SPC-GFP (26) or FoxJ1-GFP (25) transgenic mice for the identification of alveolar type 2 cells (Figure 2A) and ciliated cells, respectively. Immunofluorescence analysis of lung tissue for GFP expression revealed a punctuate distribution of parenchymal alveolar type 2 cells that showed high levels of GFP immunoreactivity and distal conducting airway cells that showed weak GFP immunoreactivity (Figure 2). Similarly, cells dissociated from lungs of SPC-GFP transgenic mice revealed a large population of GFPhigh cells with minor populations of GFPmedium-low cells. Flow cytometric analysis showed that GFPhi cells were Sca1neg and that GFPmed and GFPlow cells were Sca1low (Figure 2B). Conversely, analysis of cells from lungs of FoxJ1-GFP mice revealed a single population of GFP-expressing cells, consistent with previous analysis of this line that indicated GFP expression within ciliated cells (25). Green fluorescent protein-expressing ciliated cells were largely Sca-1low and absent from the large populations of cells showing a Sca-1neg staining pattern (Figure 2C).

Figure 2.

Figure 2.

Molecular validation of cell fractionation strategy. (A) Immunofluorescence detection of green fluorescent protein (GFP) and CCSP within lung tissue of SPC-GFP mice. Representative photomicrographs are shown demonstrating the distribution of CCSP immunoreactivity (red), GFP immunoreactivity (green), and DAPI unclear counterstaining (blue). GFP immunoreactivity reveals GFPhi, GFPlow, and GFPneg epithelial cells on lung sections from SPC-GFP mice. GFPhi cells are CCSPneg and confined to the epithelium of the lung parenchyma (arrowhead). GFPlow cells localize to terminal bronchioles and are CCSPpos (closed arrow). CCSPpos cells of proximal intrapulmonary conducting airways are GFPneg (open arrow). (B) GFPhi cells from SPC-GFP transgenic mice are superimposed over an EpCAM/Sca-1 dot plot of the viable Linneg population. GFPhi type II cells are predominantly EpCAMposSca-1neg. (C) GFPhi cells from FoxJ1-GFP transgenic mice are superimposed over an EpCAM/Sca-1 dot plot of the viable Linneg population. GFPhi ciliated cells are predominantly EpCAMposSca-1low. (D) Analysis of mRNA abundance for CCSP, SftpC, and FoxJ1 in cells fractionated according to their cell surface profile and autofluorescence characteristics. Data are presented for the indicated cell fractions relative to values obtained for total lung RNA.

Quantitative real-time PCR analysis was performed to further validate the cell type–specific composition of fractionated EpCAMpos epithelial cell preparations. The abundance of CCSP mRNA was significantly enriched within total RNA isolated from AFhi and AFlow fractions and depleted within total RNA from the Sca-1neg fraction relative to total viable lung cells (Figure 2). High levels of FoxJ1 mRNA were only observed within the AFlow fraction (Figure 2D), a finding that was consistent with the partitioning of GFPpos ciliated cells from FoxJ1-GFP transgenic mice within this fraction (Figure 2C). Expression of SftpC mRNA was greatly enriched within the Sca-1neg fraction, partially enriched within AFlow, and absent from AFhi (Figure 2D). Collectively, these data suggest that the AFhi fraction harbors CCSPhi Clara cells and that the AFlow fraction harbors a mixed population of ciliated and CCSPlow nonciliated cells. Alveolar type 2 cells, the putative progenitor for the alveolar epithelium, are selectively enriched within the Sca-1neg fraction.

Functional Analysis of Epithelial Progenitor Cells In Vivo

We next sought to determine how epithelial cell types contained within the Sca-1neg, AFhi, and AFlow populations behaved in vivo after airway injury. In other studies, Clara cells represent the only proliferative progenitor after ozone exposure and generate progeny that assume Clara or ciliated cell fates. In contrast, two subsets of CCSP-expressing cells can be delineated based upon resistance or sensitivity to naphthalene. Our data demonstrate that CCSP-expressing cells are present in AFhi and AFlow fractions and that AFlow cells are more numerous after β-catenin–mediated expansion of naphthalene-resistant bronchiolar progenitor cells (Ref. 22 and Figure 1). We used naphthalene and ozone injury models to determine whether the fractionation strategy described above was capable of separating these progenitor cell pools. We initially exposed wild-type C57Bl/6 mice to naphthalene and allowed them to recover for 3 days. Bromodeoxy-uridine (BrdU) was administered by intraperitoneal injection every 12 hours to naphthalene-injured and control mice to label proliferative cell types. Cells were isolated from control and naphthalene-treated lungs, and the distribution of BrdU-labeled cells was determined as a function of cell surface phenotype and autofluorescence characteristics (Figure 3A). To confirm Clara cell injury, we assessed the intracellular complexity (SSC) of the EpCAMpos population in injured and uninjured control mice. Cells with high intracellular complexity (SSChi, granular Clara cells) are effectively depleted 3 days after naphthalene administration (Figure 3A). Furthermore, analysis of the AFhi population revealed a significant decrease in their abundance after naphthalene exposure (60.5–22.4% in control versus treated mice). Proliferating cells were identified by gating for BrdU-labeled cells using stained cells from mice not treated with BrdU as the negative control. Using this approach, the BrdU-labeling index was determined to be 0.3 and 1.2% of EpCAMpos cells in steady-state and naphthalene-injured airways, respectively. In control and naphthalene-injured populations, greater than 70% of proliferating cells were found in the Sca-1low fraction. Cells labeled with BrdU after naphthalene treatment were preferentially found in the AFlow fraction (13.0% in AFlow versus 5.5% in AFhi) (Figures 3A, 3C, and 3D). These data demonstrate that most cells with the AFhi phenotype are naphthalene sensitive and that AFlow cells are naphthalene resistant and responsible for the bulk of proliferation occurring in the first 3 days after naphthalene-induced airway injury.

Figure 3.

Figure 3.

In vivo behavior of Linneg EpCAMpos Sca-1pos progenitor cells during lung injury and repair. Proliferating cells were labeled with 5-bromo-2′-deoxyuridine (BrdU) after injury by exposure to (A) naphthalene or (B) ozone, using unexposed mice as controls. Isolated cells were permeabilized and stained for detection of cell surface markers or nuclear BrdU. BrdU-positive events (black dots) are superimposed on total events (gray dots) on dot plots of Linneg cells displayed as a function of side scatter (SSC, left panels), Sca-1 versus EpCAM (center panels), or BrdU labeling versus autofluorescence (right panels). (C) Frequency of BrdU-labeled cells within EpCAMpos cells in control lungs or lungs from mice with ozone injury or naphthalene (Naph.) injury. (D and E) Quantitative data for BrdU labeling within AFhi and AFlow fractions of control or injured lungs for naphthalene or ozone exposures.

To determine the proliferative capacity of AFhi and AFlow cell populations after ozone injury, C57Bl/6 mice were exposed to 1.5 ppm ozone for 12 hours. To label proliferating cells, filtered air (control)–exposed and ozone-exposed mice were treated with BrdU every 12 hours over a 60-hour period. In contrast to naphthalene injury, no changes were observed in the SSChi population after ozone exposure, demonstrating that ozone does not deplete Clara cells (Figures 3B, 3C, and 3E). A decrease was observed in the size of the AFlow fraction, which is consistent with the known selectivity of ozone for ciliated cells and with our earlier data demonstrating enrichment of ciliated cells within this fraction (Figures 2A, 2C, 3B, and 3E). Cells labeled with BrdU were of high and intermediate granularity, consistent with a Clara cell phenotype, and accounted for 0.4 and 6.6% of the EpCAMpos fraction of lung cells in control and ozone-exposed mice, respectively (Figure 3B). In control and ozone-injured populations, greater than 75 and 95%, respectively, of proliferating cells were found in the Sca-1low fraction. Cells labeled with BrdU were preferentially found in the AFhi fraction of EpCAMpos/Sca-1low cells (3.2% in AFlow versus 10.6% in AFhi) (Figure 3B–3D). These data suggest that ciliated cells of the AFlow fraction are ozone sensitive and that AFhi cells are responsible for the bulk of proliferation occurring after ozone-induced airway injury.

In Vitro Behavior of Isolated Airway Epithelial Progenitor Cells

A clonogenic assay was used to reveal their clonogenic behavior in the absence of differences in microenvironment-specific extrinsic signals. Linneg/7AADneg/EpCAMpos cells were sorted from lungs of ROSA26-EGFP mice (a germline recombined variant of ROSA-R/G). Reanalysis of sorted populations indicated that purity of the EpCAMpos population was greater than 99%. Cells were then cultured in growth factor–reduced Matrigel. Under these conditions, when EpCAMpos lung cells were cultured alone, no significant colony-forming ability was observed (Figures 4A and 4H). However, when EpCAMpos lung cells were cocultured with mouse lung stromal (MLg) cells, the growth of spherical colonies was observed (Figures 4B and 4H). Colony-forming efficiency was further enhanced by approximately 4-fold (from 1 to 4%) by addition of the Alk5 inhibitor SB431542 (Figures 4C and 4H). Media additives, including noggin (0.1 μg/ml), the Rho kinase inhibitor Y-27632 (10 μg/ml), and Jagged-1 (1 μM), all of which have previously been shown to facilitate in vitro propagation of intestinal epithelial stem/progenitor cells (30), had no effect on colony growth in the absence or presence of MLg cells (data not shown). Dual immunofluorescent staining for GFP and the epithelial cell–specific marker cytokeratin 18 revealed that all colonies derived from GFPpos/EpCAMpos cells were of epithelial origin (Figures 4D–4F). Coculture of equivalent numbers of input EpCAMpos cells from ROSA-EGFP or ROSA-R/G transgenic mice resulted in the formation of either green or red colonies with no evidence of mixing. These data suggest that colonies are derived from single cells (Figure 4G). Next we used lineage tracing to determine the identity of the epithelial cells responsible for colony formation. We have shown previously that CCSP-expressing cells are necessary for airway repair in vivo (13, 14). To determine roles for CCSP-expressing cells in the formation of epithelial colonies in vitro, we enriched GFP-expressing lineage-tagged cells from tamoxifen-treated CCSPcreER ROSA-R/G mice and evaluated their colony-forming ability in culture. These cells gave rise to GFPpos colonies similar to those generated using total EpCAMpos cells (compare Figures 4C and 4I). Because the lineage tracing strategy had the potential to include nascent ciliated cells (derived from lineage-tagged CCSP-expressing progenitors) as well as CCSP-expressing cells, we sought to exclude the possibility that ciliated cells give rise to colonies. Thus, GFPpos cells from FoxJ1-GFP transgenic mice were isolated and cultured in the same conditions. These cells did not form epithelial colonies, demonstrating that CCSP-expressing cells were the only bronchiolar epithelial cells with colony-forming ability (Figure 4J). To exclude a potential ATII origin of colonies, GFPhi cells from SPC-GFP transgenic mice were isolated and cultured in parallel with CCSP-lineage tagged cells or FoxJ1-GFPpos cells. No colony formation was observed under these conditions, demonstrating that the only cells with colony-forming ability within the EpCAMpos fraction of total lung cells were of the CCSP-expressing phenotype.

Figure 4.

Figure 4.

In vitro culture model for propagation of epithelial progenitor cells. Culture conditions were optimized using a Linneg/EpCAMpos cell population of β-actin/GFP transgenic mice. Representative images of Day 6 cultures of cells seeded in growth factor–reduced Matrigel and cultured under (A) basic medium (BM), (B) BM and in the presence of mouse lung fibroblast cells (MLg), or (C) BM supplemented with SB431542 in the presence of MLg cells (1 × 104 cells/condition). (D) Analysis of cytokeratin (CK)-18 expression within GFPpos colonies by dual immunofluorescence analysis. Photomicrographs demonstrate CK-18–immunoreactive cells (D), GFP-immunoreactive cells (E), and a merged image showing coexpression of CK-18 and GFP (F). DAPI is included as a nuclear counterstain (blue). (G) Analysis of clonality of epithelial colonies. Linneg EpCAMpos cells were isolated from mice expressing ubiquitous GFP (green signal) or TdTomato (red signal) and cocultured in the presence of MLg cells and SB431542. No mixing of red and green fluorescent cells is observed within individual colonies, indicating their clonal origin. (H) Quantitative analysis of the colony-forming ability of Linneg/EpCAMpos cells in BM, BM+MLg, and BM+MLg+SB431542. Cultures of GFP+ cells (input cell number: 5,000) from lineage tracing mice, (I) CCSPcreER, (J) SPC-GFP, and (K) FoxJ1-GFP were photographed at Day 6. Scale bars: 200 μm for A, B, C, G, I, J, and K; 100 μm for F.

Using this coculture assay and SB431542 supplementation, we have shown that colony-forming progenitor cells are contained within the AFhi and AFlow fractions (Figures 5A and 5B). However, differences were observed in colony-forming efficiency between the AFhi and AFlow fractions. The colony-forming efficiency of the AFhi cell fraction was approximately 10.4% (Figures 5A and 5B). In contrast, the AFlow cell fraction gave rise to colonies with a frequency of approximately 1.1% (Figures 5A and 5B). The lower colony-forming efficiency of cells within the AFlow fraction is consistent with earlier data, revealing that this population includes ciliated cells and significantly lower numbers of CCSP-immunoreactive cells relative to the AFhi fraction (see Figures 1D–1F and 2). These data suggest that colony-forming efficiency is directly related to the incidence of progenitor cells contained within each fraction.

Figure 5.

Figure 5.

In vitro behavior of epithelial progenitor cells from wild-type mice and CatnbΔE3 mice with conditional potentiation of β-catenin signaling within airways. (A) Isolated cells from GFP transgenic mice (WT) or tritransgenic mice β-actin–GFP/CCSP-cre/CatnbfloxE3 (ΔE3) were sorted into Linneg EpCAMpos Sca-1pos AFhi (WT AFhi) and Linneg EpCAMpos Sca-1pos AFlow (WT AFlow or ΔE3 AFlow) and cocultured with MLg fibroblasts in basic medium supplemented with SB431542. GFP fluorescence images were captured on Day 6 after plating (3 × 104 epithelial cells/ml Matrigel). (B) Clonogenic frequency of cells in each fraction shown in A. (C) Serial passage of epithelial colonies from the indicated cell fractions (*P < 0.05).

To better establish the relationship between in vivo progenitor cell activity and colony-forming ability in vitro, we determined the colony-forming efficiency of AFlow cells recovered from lungs of CatnbΔE3 mice. Airway epithelial cells of CatnbΔE3 mice have an expanded pool of naphthalene-resistant AFlow airway progenitor cells due to ectopic activation of canonical Wnt signaling (16). In vitro culture of AFlow airway progenitor cells from CatnbΔE3 mice yielded colonies with the same morphologic features as those generated from AFhi and AFlow cells from wild-type mice (Figure 5A). However, the colony-forming efficiency of AFlow cells from CatnbΔE3 mice was increased by 13-fold over that observed in cultures of wild-type AFlow cells (1.1% for wild type versus 14.3% for CatnbΔE3) (Figures 5A and 5B). These data further support the conclusion that our culture system is sufficient for the clonal growth of bronchiolar progenitor cells within fractionated lung cell preparations.

Cultured epithelial cells were passaged to assess the self-renewal potential of AFhi or AFlow fractions of wild-type and CatnbΔE3 mice. Colony-forming efficiency was assessed in 5-day cultures during the active growth phase of epithelial colonies and before harvesting cells for serial passage. In 5-day cultures AFhi, AFlow, and CatnbΔE3AFlow cells were found to show 2.4, 0.5, and 9.3% colony-forming efficiency, respectively (Figure 5C). Harvesting and reseeding of sorted GFPpos epithelial cells from AFhi and AFlow cultures were associated with increases in colony-forming efficiency to 4.8 and 4.5%, with no significant change observed between passages P1 and P2 (Figure 5C). No further increases in colony-forming efficiency were observed with serial passage of GFPpos cells from CatnbΔE3 mice (Figure 5C). These data suggest that the initial in vitro expansion of epithelial progenitor cells within wild-type AFhi and AFlow fractions results in selection of progenitor cells that exhibit a similar capacity for self-renewal. Furthermore, genetic potentiation of β-catenin signaling within AFlow cells from CatnbΔE3 results in an increase in clonogenic potential.

DISCUSSION

We have validated a refined fractionation approach that yields three distinct epithelial progenitor cell fractions that encompass bronchiolar and alveolar compartments. When coupled with established mouse lung injury models, progenitor cells contributing to repair after ozone-induced depletion of ciliated cells are predominantly localized to a lung cell fraction characterized by CD45negCD34negCD31negEpCAMposSca-1lowAFhi. Cells within this fraction are predominantly composed of CCSP-expressing, naphthalene-sensitive Clara cells, a finding that is consistent with data from other laboratories that this cell type represents the proliferative progenitor cell after ozone- or nitrogen dioxide–induced airway injury (7). We show that the pool of progenitor cells that proliferate in response to naphthalene-induced Clara cell ablation is principally CD45negCD34negCD31negEpCAMposSca-1lowAFlow. These cells lack cellular complexity and express low levels of CCSP, characteristics that distinguish them from Clara cells present within the AFhi fraction. Our past and present findings in vivo suggest that naphthalene-resistant CCSPlow cells (AFlow) exhibit distinct functional properties to the broader population of naphthalene-sensitive CCSPhi Clara cells (AFhi).

Roles for Clara cells in epithelial maintenance have recently been reevaluated based upon findings by Giangreco and colleagues and Rawlins and colleagues using somatic chimeras or lineage tracing approaches to follow the behavior of airway progenitors (18, 19). These studies are in agreement that an abundant progenitor rather than a rare undifferentiated progenitor contributes to normal epithelial maintenance in the uninjured state. An important question is whether relatively quiescent tissues such as the lung harbor latent tissue stem cells that can be distinguished from an abundant pool of progenitor cells involved in normal tissue maintenance (8, 1315, 31, 1719, 32). We and others have previously used naphthalene exposure to functionally distinguish Clara cells from a pool of naphthalene-resistant progenitor cells that exhibit some characteristics of tissue stem cells (1315, 17, 19). In the present study, we have functionally verified that epithelial progenitor cells contributing to airway renewal after naphthalene-induced lung injury are selectively enriched within the CD45negCD34negCD31negEpCAMposSca-1lowAFlow fraction of dissociated lung cells. Naphthalene-resistant progenitor cells have a more restricted distribution within bronchioles than Clara cells, suggesting that regional differences in the airway microenvironment may contribute to their unique behavior (8, 13, 14).

Recent findings in the hematopoietic, hair follicle, and intestinal systems suggest the existence of two separate stem cell pools: A population of stem cells proliferates frequently and is thought to be responsible for normal tissue maintenance, while a “reserve” stem cell population is mainly quiescent and can be mobilized during the repair process after injury (reviewed by Li and Clevers [33]). Similarly, we demonstrate the existence of two distinct progenitor pools in the bronchiolar epithelium with distinct phenotype and functional behavior. Due to the low proliferative index of steady-state epithelium, specific injury models were used to reveal the proliferative potential of these two fractions of AFhi and AFlow cells. Thus, AFhi cells replenish the pool of terminally differentiated ciliated cells depleted during ozone injury, whereas the proliferative potential of AFlow cells is only revealed in a more severe injury model that specifically targets the more abundant pool of AFhi (Clara) cells. However, whether airway progenitor cells represent functionally distinct stem cell pools, such as those in the gut, skin, and hematopoietic systems, or whether they are more representative of other progenitor cell relationships, such as that between follicular bulge stem cells versus interfollicular keratinocytes, has yet to be determined.

We used an in vitro model to determine how subpopulations of bronchiolar progenitor cells that show functionally distinct properties in vivo behave when placed in a homogeneous culture environment. We demonstrated that only cells tagged by ligand activation of a CCSP promoter–driven CreER recombinase developed epithelial colonies in vitro. Neither ciliated nor alveolar type 2 cells demonstrated colony-forming ability in our in vitro assay. These data are consistent with our previous findings that CCSP-expressing cells of conducting airways are necessary for epithelial maintenance and repair (13, 14). Based on the size and growth pattern of individual colonies, we found that progenitor cells within AFhi or AFlow fractions of lung epithelial cells displayed very similar capacities for clonal growth and in each case were maintained long after serial passage. Furthermore, both populations of bronchiolar progenitors gave rise to morphologically similar colonies under the conditions of culture used. In related studies, it was recently shown that an EpCAMhi fraction of lung cells includes progenitors that can generate three colony types when cultured in the presence of EpCAMnegSca-1pos primary lung stromal cells (34). Under these conditions, epithelial colonies displayed molecular characteristics indicative of airway, alveolar, or mixed differentiation. Differences in the outcomes of these studies reinforce the impact that microenvironmental cues, provided by the in vitro culture environment or through the natural heterogeneity of the in vivo environment, regulate the clonogenic behavior and differentiation potential of epithelial progenitor cells. Dynamic interactions between developing lung endoderm and surrounding mesoderm play critical roles in patterning branching airways and lineage specification (5, 35). Our data suggest that interactions between epithelial and stromal components are critical for clonal expansion of adult bronchiolar epithelial progenitor cells and play important roles in regulating their differentiation. Potentiation of clonal growth by SB431542-mediated inhibition of TGFβRI/ALK5 signaling provides insight into potential regulatory mechanisms that may operate in normal tissue maintenance in vivo. TGF-β signaling has been shown to inhibit the proliferation of epithelial cells in several organs, including the lung, and has been proposed as a mediator of defective epithelial maintenance in the asthmatic airway (3639). Other candidate signaling pathways that may regulate bronchiolar progenitor cells include PTEN pathways (40, 41), the mitogen-activated protein kinase pathway (42), Wnt (16, 43, 44), and pathways regulating the activity of K-ras/PI-3–kinase (17, 45, 46). Further in vitro analysis of molecular signals regulating the behavior of bronchiolar progenitor cells will provide important insights into intrinsic versus microenvironmental control mechanisms that differentially regulate their behavior in normal tissue maintenance or in the remodeling that accompanies chronic lung disease.

Acknowledgments

The authors thank Brian Brockway, Jeffrey Drake, Lixia Luo, and Karen Terry for technical assistance.

This work was supported by NHLBI grants HL064888, HL090146, and HL089141.

Originally Published in Press as DOI: 10.1165/rcmb.2010-0098OC on July 23, 2010

Author Disclosure: I.B. received a patent from Australian Stem Cell Centre for lung epithelial progenitor cells, uses thereof, and processes for production. J.M. received a patent from Australian Stem Cell Centre for lung epithelial progenitor cells, uses thereof, and processes for production. H.C. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. W.M.F. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. E.N.P. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. K.M. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. B.R.S. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. R.M.T. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript.

References

  • 1.Snyder JC, Teisanu RM, Stripp BR. Endogenous lung stem cells and contribution to disease. J Pathol 2009;217:254–264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Neuringer IP, Randell SH. Stem cells and repair of lung injuries. Respir Res 2004;5:6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Rawlins EL, Hogan BL. Epithelial stem cells of the lung: privileged few or opportunities for many? Development 2006;133:2455–2465. [DOI] [PubMed] [Google Scholar]
  • 4.Rawlins EL, Clark CP, Xue Y, Hogan BL. The Id2+ distal tip lung epithelium contains individual multipotent embryonic progenitor cells. Development 2009;136:3741–3745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Shannon JM. Induction of alveolar type II cell differentiation in fetal tracheal epithelium by grafted distal lung mesenchyme. Dev Biol 1994;166:600–614. [DOI] [PubMed] [Google Scholar]
  • 6.Evans MJ, Johnson LV, Stephens RJ, Freeman G. Renewal of the terminal bronchiolar epithelium in the rat following exposure to NO2 or O3. Lab Invest 1976;35:246–257. [PubMed] [Google Scholar]
  • 7.Evans MJ, Cabral-Anderson LJ, Freeman G. Role of the Clara cell in renewal of the bronchiolar epithelium. Lab Invest 1978;38:648–653. [PubMed] [Google Scholar]
  • 8.Stripp BR, Maxson K, Mera R, Singh G. Plasticity of airway cell proliferation and gene expression after acute naphthalene injury. Am J Physiol 1995;269:L791–L799. [DOI] [PubMed] [Google Scholar]
  • 9.Buckpitt AR, Franklin RB. Relationship of naphthalene and 2-methylnaphthalene metabolism to pulmonary bronchiolar epithelial cell necrosis. Pharmacol Ther 1989;41:393–410. [DOI] [PubMed] [Google Scholar]
  • 10.Plopper CG, Chang AM, Pang A, Buckpitt AR. Use of microdissected airways to define metabolism and cytotoxicity in murine bronchiolar epithelium. Exp Lung Res 1991;17:197–212. [DOI] [PubMed] [Google Scholar]
  • 11.Plopper CG, Van Winkle LS, Fanucchi MV, Malburg SR, Nishio SJ, Chang A, Buckpitt AR. Early events in naphthalene-induced acute Clara cell toxicity. II: comparison of glutathione depletion and histopathology by airway location. Am J Respir Cell Mol Biol 2001;24:272–281. [DOI] [PubMed] [Google Scholar]
  • 12.Warren DL, Brown DL Jr, Buckpitt AR. Evidence for cytochrome P-450 mediated metabolism in the bronchiolar damage by naphthalene. Chem Biol Interact 1982;40:287–303. [DOI] [PubMed] [Google Scholar]
  • 13.Giangreco A, Reynolds SD, Stripp BR. Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am J Pathol 2002;161:173–182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Hong KU, Reynolds SD, Giangreco A, Hurley CM, Stripp BR. Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. Am J Respir Cell Mol Biol 2001;24:671–681. [DOI] [PubMed] [Google Scholar]
  • 15.Reynolds SD, Giangreco A, Power JH, Stripp BR. Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration. Am J Pathol 2000;156:269–278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Reynolds SD, Zemke AC, Giangreco A, Brockway BL, Teisanu RM, Drake JA, Mariani T, Di PY, Taketo MM, Stripp BR. Conditional stabilization of beta-catenin expands the pool of lung stem cells. Stem Cells 2008;26:1337–1346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT, Jacks T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005;121:823–835. [DOI] [PubMed] [Google Scholar]
  • 18.Rawlins EL, Okubo T, Xue Y, Brass DM, Auten RL, Hasegawa H, Wang F, Hogan BL. The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell 2009;4:525–534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Giangreco A, Arwert EN, Rosewell IR, Snyder J, Watt FM, Stripp BR. Stem cells are dispensable for lung homeostasis but restore airways after injury. Proc Natl Acad Sci USA 2009;106:9286–9291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Giangreco A, Shen H, Reynolds SD, Stripp BR. Molecular phenotype of airway side population cells. Am J Physiol Lung Cell Mol Physiol 2004;286:L624–L630. [DOI] [PubMed] [Google Scholar]
  • 21.Summer R, Kotton DN, Sun X, Ma B, Fitzsimmons K, Fine A. Side population cells and Bcrp1 expression in lung. Am J Physiol Lung Cell Mol Physiol 2003;285:L97–L104. [DOI] [PubMed] [Google Scholar]
  • 22.Teisanu RM, Lagasse E, Whitesides JF, Stripp BR. Prospective isolation of bronchiolar stem cells based upon immunophenotypic and autofluorescence characteristics. Stem Cells 2009;27:612–622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.McQualter JL, Brouard N, Williams B, Baird BN, Sims-Lucas S, Yuen K, Nilsson SK, Simmons PJ, Bertoncello I. Endogenous fibroblastic progenitor cells in the adult mouse lung are highly enriched in the sca-1 positive cell fraction. Stem Cells 2009;27:623–633. [DOI] [PubMed] [Google Scholar]
  • 24.Rock JR, Onaitis MW, Rawlins EL, Lu Y, Clark CP, Xue Y, Randell SH, Hogan BL. Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc Natl Acad Sci USA 2009;106:12771–12775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ostrowski LE, Hutchins JR, Zakel K, O'Neal WK. Targeting expression of a transgene to the airway surface epithelium using a ciliated cell-specific promoter. Mol Ther 2003;8:637–645. [DOI] [PubMed] [Google Scholar]
  • 26.Lo B, Hansen S, Evans K, Heath JK, Wright JR. Alveolar epithelial type II cells induce T cell tolerance to specific antigen. J Immunol 2008;180:881–888. [DOI] [PubMed] [Google Scholar]
  • 27.Snyder JC, Zemke AC, Stripp BR. Reparative capacity of airway epithelium impacts deposition and remodeling of extracellular matrix. Am J Respir Cell Mol Biol 2009;40:633–642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Litvinov SV, Balzar M, Winter MJ, Bakker HA, Briaire-de Bruijn IH, Prins F, Fleuren GJ, Warnaar SO. Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins. J Cell Biol 1997;139:1337–1348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kasper M, Behrens J, Schuh D, Müller M. Distribution of E-cadherin and Ep-CAM in the human lung during development and after injury. Histochem Cell Biol 1995;103:281–286. [DOI] [PubMed] [Google Scholar]
  • 30.Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, van Es JH, Abo A, Kujala P, Peters PJ, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009;459:262–265. [DOI] [PubMed] [Google Scholar]
  • 31.Stripp BR. Hierarchical organization of lung progenitor cells: is there an adult lung tissue stem cell? Proc Am Thorac Soc 2008;5:695–698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Kim CB. Advancing the field of lung stem cell biology. Front Biosci 2007;12:3117–3124. [DOI] [PubMed] [Google Scholar]
  • 33.Li L, Clevers H. Coexistence of quiescent and active adult stem cells in mammals. Science 2010;327:542–545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.McQualter JL, Yuen K, Williams B, Bertoncello I. Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung. Proc Natl Acad Sci USA 107:1414–1419. [DOI] [PMC free article] [PubMed]
  • 35.Morrisey EE, Hogan BL. Preparing for the first breath: genetic and cellular mechanisms in lung development. Dev Cell 2010;18:8–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Novershtern N, Itzhaki Z, Manor O, et al. A functional and regulatory map of asthma. Am J Respir Cell Mol Biol 2008;38:324–336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Puddicombe SM, Torres-Lozano C, Richter A, Bucchieri F, Lordan JL, Howarth PH, Vrugt B, Albers R, Djukanovic R, Holgate ST, et al. Increased expression of p21(waf) cyclin-dependent kinase inhibitor in asthmatic bronchial epithelium. Am J Respir Cell Mol Biol 2003;28:61–68. [DOI] [PubMed] [Google Scholar]
  • 38.Booth D, Haley JD, Bruskin AM, Potten CS. Transforming growth factor-B3 protects murine small intestinal crypt stem cells and animal survival after irradiation, possibly by reducing stem-cell cycling. Int J Cancer 2000;86:53–59. [DOI] [PubMed] [Google Scholar]
  • 39.Lange AW, Keiser AR, Wells JM, Zorn AM, Whitsett JA. Sox17 promotes cell cycle progression and inhibits TGF-beta/Smad3 signaling to initiate progenitor cell behavior in the respiratory epithelium. PLoS ONE 2009;4:e5711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Dave V, Wert SE, Tanner T, Thitoff AR, Loudy DE, Whitsett JA. Conditional deletion of Pten causes bronchiolar hyperplasia. Am J Respir Cell Mol Biol 2008;38:337–345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Yanagi S, Kishimoto H, Kawahara K, Sasaki T, Sasaki M, Nishio M, Yajima N, Hamada K, Horie Y, Kubo H, et al. Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. J Clin Invest 2007;117:2929–2940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Ventura JJ, Tenbaum S, Perdiguero E, Huth M, Guerra C, Barbacid M, Pasparakis M, Nebreda AR. p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat Genet 2007;39:750–758. [DOI] [PubMed] [Google Scholar]
  • 43.Mucenski ML, Nation JM, Thitoff AR, Besnard V, Xu Y, Wert SE, Harada N, Taketo MM, Stahlman MT, Whitsett JA. Beta-catenin regulates differentiation of respiratory epithelial cells in vivo. Am J Physiol Lung Cell Mol Physiol 2005;289:L971–L979. [DOI] [PubMed] [Google Scholar]
  • 44.Zhang Y, Goss AM, Cohen ED, Kadzik R, Lepore JJ, Muthukumaraswamy K, Yang J, DeMayo FJ, Whitsett JA, Parmacek MS, et al. A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration. Nat Genet 2008;40:862–870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Yang Y, Iwanaga K, Raso MG, Wislez M, Hanna AE, Wieder ED, Molldrem JJ, Wistuba II, Powis G, Demayo FJ, et al. Phosphatidylinositol 3-kinase mediates bronchioalveolar stem cell expansion in mouse models of oncogenic K-ras-induced lung cancer. PLoS ONE 2008;3:e2220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R, Jacks T, Tuveson DA. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 2001;15:3243–3248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M, Taketo MM. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J 1999;18:5931–5942. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Respiratory Cell and Molecular Biology are provided here courtesy of American Thoracic Society

RESOURCES